Trevi Therapeutics, Inc. (TRVI)
NASDAQ
Market Cap
$186.65M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
775 of 809
Rank in Industry
425 of 445
Largest Insider Buys in Sector
TRVI Stock Price History Chart
TRVI Stock Performance
About Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Insider Activity of Trevi Therapeutics, Inc.
Over the last 12 months, insiders at Trevi Therapeutics, Inc. have bought $0 and sold $238,814 worth of Trevi Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Trevi Therapeutics, Inc. have bought $45.61M and sold $166,514 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,631,578 shares for transaction amount of $5M was made by NEA 16 GP, LLC () on 2022‑04‑11.
List of Insider Buy and Sell Transactions, Trevi Therapeutics, Inc.
| 2024-05-29 | Sale | SCIASCIA THOMAS | Chief Scientific Officer | 53,368 0.0761% | $2.55 | $136,110 | +3.95% | |
| 2024-05-22 | Sale | Delfini Lisa | Chief Financial Officer | 4,350 0.0062% | $2.64 | $11,485 | -0.95% | |
| 2024-05-20 | Sale | GOOD JENNIFER L | President & CEO | 25,037 0.0359% | $2.86 | $71,576 | -7.60% | |
| 2024-05-10 | Sale | GOOD JENNIFER L | President & CEO | 4,578 0.0069% | $2.90 | $13,276 | -3.30% | |
| 2023-10-11 | Sale | Delfini Lisa | Chief Financial Officer | 785 0.0012% | $2.02 | $1,586 | +20.34% | |
| 2023-09-11 | Sale | Delfini Lisa | Chief Financial Officer | 711 0.0011% | $2.20 | $1,564 | -4.42% | |
| 2023-08-11 | Sale | Delfini Lisa | Chief Financial Officer | 682 0.0011% | $2.36 | $1,610 | -8.40% | |
| 2023-07-11 | Sale | Delfini Lisa | Chief Financial Officer | 687 0.0007% | $2.34 | $1,608 | -1.54% | |
| 2023-06-12 | Sale | Delfini Lisa | Chief Financial Officer | 610 0.0006% | $2.64 | $1,610 | -11.72% | |
| 2023-05-11 | Sale | Delfini Lisa | Chief Financial Officer | 562 0.0008% | $2.89 | $1,624 | -25.50% | |
| 2023-04-11 | Sale | Delfini Lisa | Chief Financial Officer | 840 0.0013% | $1.84 | $1,545 | +20.77% | |
| 2023-03-13 | Sale | Delfini Lisa | Chief Financial Officer | 892 0.0013% | $1.75 | $1,564 | +13.90% | |
| 2023-02-13 | Sale | Delfini Lisa | Chief Financial Officer | 8,474 0.0131% | $2.45 | $20,761 | -13.47% | |
| 2022-07-01 | Sale | WINKELRIED JON | 63,569 0.0983% | $3.11 | $197,827 | -19.52% | ||
| 2022-06-29 | Sale | WINKELRIED JON | 46,128 0.0866% | $2.74 | $126,303 | -4.08% | ||
| 2022-05-02 | Sale | WINKELRIED JON | 600 0.0011% | $2.70 | $1,620 | -9.16% | ||
| 2022-04-28 | Sale | WINKELRIED JON | 16,163 0.0269% | $2.75 | $44,385 | -17.69% | ||
| 2022-04-11 | NEA 16 GP, LLC | 2.63M 3.0873% | $1.90 | $5M | -15.26% | |||
| 2022-04-11 | Makhzoumi Mohamad | 2.63M 3.0873% | $1.90 | $5M | -15.26% | |||
| 2022-04-11 | BASKETT FOREST | 2.63M 3.0873% | $1.90 | $5M | -15.26% |
Insider Historical Profitability
<0.0001%
| GOOD JENNIFER L | See Remarks | 213313 0.3229% | $2.65 | 1 | 2 | <0.0001% |
| SCIASCIA THOMAS | Chief Scientific Officer | 214433 0.3044% | $2.65 | 0 | 1 | |
| Delfini Lisa | Chief Financial Officer | 53279 0.0562% | $2.65 | 0 | 10 | |
| BASKETT FOREST | 10421428 16.3198% | $2.65 | 3 | 1 | +1.73% | |
| NEA 16 GP, LLC | 10421428 16.3198% | $2.65 | 1 | 0 | <0.0001% | |
| Makhzoumi Mohamad | 10421428 16.3198% | $2.65 | 3 | 1 | +1.73% | |
| Chang Carmen | 10 percent owner | 7789850 12.1988% | $2.65 | 2 | 1 | +10.22% |
| Behbahani Ali | 10 percent owner | 7789850 12.1988% | $2.65 | 2 | 1 | +10.22% |
| SANDELL SCOTT D | 10 percent owner | 7789850 12.1988% | $2.65 | 2 | 1 | +10.22% |
| Walker Paul Edward | 10 percent owner | 7789850 12.1988% | $2.65 | 2 | 1 | +10.22% |
| New Enterprise Associates 16, L.P. | 10 percent owner | 7789850 12.1988% | $2.65 | 2 | 1 | +10.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 10 percent owner | 6573000 10.2932% | $2.65 | 1 | 0 | <0.0001% |
| MAKOWER JOSHUA | 10 percent owner | 5937998 9.2988% | $2.65 | 1 | 1 | <0.0001% |
| MOTT DAVID M | 10 percent owner | 4438562 6.9507% | $2.65 | 1 | 0 | <0.0001% |
| BARRIS PETER J | 10 percent owner | 4438562 6.9507% | $2.65 | 1 | 0 | <0.0001% |
| WINKELRIED JON | 3824883 5.9897% | $2.65 | 0 | 4 | ||
| Agger Mette Kirstine | director | 1151544 1.8033% | $2.65 | 1 | 0 | <0.0001% |
| Lundbeckfond Invest A/S | 10 percent owner | 1151544 1.8033% | $2.65 | 1 | 0 | <0.0001% |
| Omega Fund V, L.P. | 10 percent owner | 1063408 1.6653% | $2.65 | 1 | 0 | <0.0001% |
| Sonsini Peter W. | 948948 1.486% | $2.65 | 3 | 1 | +1.73% | |
| Florence Anthony A. Jr. | 948948 1.486% | $2.65 | 3 | 1 | +1.73% | |
| Meeker David P | 352489 0.552% | $2.65 | 1 | 0 | <0.0001% | |
| Mellon Family Investment Co V | 10 percent owner | 347156 0.5436% | $2.65 | 1 | 0 | <0.0001% |
| Richard King Mellon Foundation | 10 percent owner | 347157 0.5436% | $2.65 | 1 | 0 | <0.0001% |
| Aperture Venture Partners IV, L.P. | 10 percent owner | 344963 0.5402% | $2.65 | 1 | 0 | <0.0001% |
| VANLENT ANNE | director | 25983 0.0407% | $2.65 | 1 | 0 | <0.0001% |
| Heffernan Michael Thomas | director | 6351 0.0099% | $2.65 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Nea Management Company Llc | $39.23M | 16.14 | 11.37M | 0% | +$0 | 0.45 | |
| Frazier Life Sciences Management L P | $25.46M | 10.48 | 7.38M | 0% | +$0 | 1.31 | |
| Helm Capital Management LLC | $19.2M | 7.9 | 5.56M | -2.12% | -$415,024.64 | 0.57 | |
| Viking Global Investors | $15.18M | 6.25 | 4.4M | 0% | +$0 | 0.01 | |
| Vr Adviser Llc | $11.81M | 4.86 | 3.42M | +<0.01% | +$959.10 | 0.57 | |
| Opaleye Management Inc | $9.13M | 3.76 | 2.65M | +4.34% | +$379,500.00 | 1.44 | |
| BlackRock | $8.2M | 3.37 | 2.38M | +2.41% | +$193,175.85 | <0.0001 | |
| The Vanguard Group | $7.95M | 3.27 | 2.3M | +2.69% | +$207,859.06 | <0.0001 | |
| Logos Global Management Lp | $7.59M | 3.12 | 2.2M | New | +$7.59M | 0.82 | |
| Bioimpact Capital Llc | $4.63M | 1.9 | 1.34M | New | +$4.63M | 0.75 | |
| MAI Capital Management, LLC | $3.9M | 1.61 | 1.13M | -11.54% | -$509,347.59 | 0.04 | |
| Geode Capital Management | $3.1M | 1.28 | 897,965 | +5.66% | +$165,908.31 | <0.0001 | |
| Silverarc Capital Management Llc | $2.91M | 1.2 | 844,235 | -2.27% | -$67,785.61 | 0.86 | |
| State Street | $2.75M | 1.13 | 798,249 | +7.7% | +$196,843.20 | <0.0001 | |
| Landscape Capital Management | $2.55M | 1.05 | 740,128 | -18.68% | -$586,382.79 | 0.22 | |
| Northern Trust | $1.13M | 0.47 | 327,692 | +4.3% | +$46,623.28 | <0.0001 | |
| Simplify Asset Management Inc | $690,000.00 | 0.28 | 200,000 | New | +$690,000.00 | 0.07 | |
| J. Goldman & Company | $475,662.00 | 0.2 | 137,873 | 0% | +$0 | 0.02 | |
| BNY Mellon | $443,763.00 | 0.18 | 128,627 | -3.56% | -$16,401.29 | <0.0001 | |
| Renaissance Technologies | $403,000.00 | 0.17 | 116,842 | -78.47% | -$1.47M | <0.01 | |
| Shay Capital Llc | $392,134.00 | 0.16 | 113,662 | New | +$392,134.00 | 0.12 | |
| Charles Schwab | $371,589.00 | 0.15 | 107,707 | 0% | +$0 | <0.0001 | |
| Bridgeway Capital Management | $332,859.00 | 0.14 | 96,481 | -54.38% | -$396,749.46 | 0.01 | |
| Nuveen | $258,229.00 | 0.11 | 74,849 | 0% | +$0 | <0.0001 | |
| Morgan Stanley | $235,382.00 | 0.1 | 68,227 | -54.21% | -$278,675.84 | <0.0001 | |
| Wealthtrust Axiom Llc | $219,075.00 | 0.09 | 63,500 | 0% | +$0 | 0.07 | |
| Oppenheimer Holdings | $208,432.00 | 0.09 | 60,415 | New | +$208,432.00 | <0.01 | |
| RhumbLine Advisers | $179,238.00 | 0.07 | 51,955 | +0.95% | +$1,693.89 | <0.0001 | |
| American Century Investments | $159,411.00 | 0.07 | 46,206 | +119.37% | +$86,743.51 | <0.0001 | |
| Atom Investors Lp | $157,789.00 | 0.07 | 45,736 | +15.36% | +$21,003.57 | 0.02 | |
| UBS | $145,307.00 | 0.06 | 42,118 | +34.23% | +$37,056.42 | <0.0001 | |
| Bailard Inc | $141,105.00 | 0.06 | 40,900 | New | +$141,105.00 | <0.01 | |
| Goldman Sachs | $131,010.00 | 0.05 | 37,974 | +58.79% | +$48,503.44 | <0.0001 | |
| Tejara Capital Ltd | $129,309.00 | 0.05 | 37,481 | -97.05% | -$4.25M | 0.04 | |
| Trust Co Of Toledo Na Oh | $125,932.00 | 0.05 | 36,502 | 0% | +$0 | 0.02 | |
| LINSCO PRIVATE LEDGER CORP | $124,200.00 | 0.05 | 36,000 | New | +$124,200.00 | <0.0001 | |
| Barclays | $122,000.00 | 0.05 | 35,195 | -44.83% | -$99,146.01 | <0.0001 | |
| Citadel Advisors LLC | $98,946.00 | 0.04 | 28,680 | -84.5% | -$539,504.10 | <0.0001 | |
| UNITED BANK | $98,153.00 | 0.04 | 28,450 | 0% | +$0 | 0.01 | |
| JPMorgan Chase | $87,848.00 | 0.04 | 25,463 | -5.63% | -$5,244.04 | <0.0001 | |
| Dimensional Fund Advisors | $78,436.00 | 0.03 | 22,735 | New | +$78,436.00 | <0.0001 | |
| MetLife Investment Management | $78,291.00 | 0.03 | 22,693 | New | +$78,291.00 | <0.01 | |
| Ameriprise Financial | $74,547.00 | 0.03 | 21,608 | New | +$74,547.00 | <0.0001 | |
| Bank of America | $75,817.00 | 0.03 | 21,976 | -47.67% | -$69,055.02 | <0.0001 | |
| American International Group | $71,667.00 | 0.03 | 20,773 | -0.85% | -$614.10 | <0.0001 | |
| Invesco | $68,613.00 | 0.03 | 19,888 | 0% | +$0 | <0.0001 | |
| Jump Financial Llc | $63,621.00 | 0.03 | 18,441 | New | +$63,621.00 | <0.01 | |
| Deutsche Bank | $61,469.00 | 0.03 | 17,817 | New | +$61,469.00 | <0.0001 | |
| Wells Fargo | $58,095.00 | 0.02 | 16,839 | +29.91% | +$13,375.75 | <0.0001 | |
| Jane Street Capital | $58,974.00 | 0.02 | 17,094 | -74.08% | -$168,562.69 | <0.0001 |